RRP40 antibodies are designed to recognize the EXOSC3 protein, a non-catalytic cap subunit of the RNA exosome complex. This complex possesses 3'→5' exoribonuclease activity and participates in RNA surveillance, processing, and turnover . RRP40 is evolutionarily conserved, with homologs identified in Saccharomyces cerevisiae (Rrp40), Drosophila melanogaster, and humans .
Applications: Western blot (WB), ELISA, immunohistochemistry (IHC), immunoprecipitation (IP) .
Reactivity: Species-specific variants available for humans, mice, rats, yeast, and Drosophila .
Commercial Availability: 13 products across 6 suppliers, including monoclonal and polyclonal options .
RRP40 interacts with activation-induced cytidine deaminase (AID) to promote class-switch recombination (CSR) in B cells:
Mechanism: RRP40 knockdown in CH12F3 B cells reduces CSR efficiency by 50–70% without affecting AID expression or transcription of target loci .
Chromatin Recruitment: RRP40 associates with transcribed switch (S) regions in an AID-dependent manner, facilitating DNA deamination .
Studies in Drosophila reveal RRP40’s essential role in neuronal development and homeostasis:
Developmental Lethality: Global RRP40 depletion causes embryonic lethality, while neuronal-specific depletion leads to adult locomotor defects and reduced lifespan .
Mushroom Body Defects: RRP40-deficient flies exhibit α-lobe thinning and β-lobe fusion in brain structures critical for learning and memory .
A monoclonal RRP40 antibody (MMp40) demonstrates utility in distinguishing squamous cell carcinomas (SqCC) from adenocarcinomas (ADC):
Cancer Type | MMp40 Positivity | p63 Positivity | Specificity |
---|---|---|---|
Lung SqCC (n=107) | 94.4% | 85% | 99.2% |
Lung ADC (n=121) | 0.8% | 18% | 98% |
Urothelial Carcinoma | 100% | N/A | High |
Breast/Prostate Cancers | 0% | N/A | 100% |
Data sourced from immunohistochemical studies comparing MMp40 with p63 .
Missense mutations in EXOSC3 (e.g., G11A, D87A) linked to pontocerebellar hypoplasia type 1B (PCH1B) alter RNA exosome function:
Transcriptomic Dysregulation: RNA-seq of Drosophila RRP40 mutants reveals increased levels of non-coding RNAs (e.g., lncRNAs, snoRNAs) and synaptic regulators like Arc1, correlating with neuronal dysfunction .
Rescue Experiments: Neuronal expression of human EXOSC3 restores climbing ability in mutant flies but fails to rescue viability, indicating developmental-stage-specific requirements .
KEGG: sce:YOL142W
STRING: 4932.YOL142W